The Relationship between the HATCH Score, Neutrophil to Lymphocyte Ratio and Postoperative Atrial Fibrillation After Off-Pump Coronary Artery Bypass Graft Surgery
Keywords:Off-Pump Coronary Artery Bypass, Atrial fibrillation, HATCH score, Neutrophil to lymphocyte ratio
Backround: Postoperative atrial fibrillation (PoAF), the most common arrythmia observed in 18-40% of patients following coronary artery bypass surgery, may cause hemodynamic disturbances and increase embolism risk. The aim of this study was to investigate the relationship of HATCH score with PoAF in patients who underwent off-pump coronary artery bypass grafting (OPCABG) and evaluate the effect of preoperatively calculated neutrophil-to-lymphocyte ratio (NLR)
Methods: Patients who underwent OPCABG between January 2014 and January 2019 were included in the study. Preoperative and postoperative data retrospectively were obtained. Patients who did not develop PoAF during the postoperative hospitalization period constituted Group 1; those who did were classified as
Results: Ninety-seven patients (69 males and 28 females) with a mean age of 54.4 ± 11.1 years constituted Group 1, and 26 patients (17 males and 9 females) with a mean age of 61±12.6 years constituted Group 2. Significant differences were observed between the 2 groups, in terms of age and HATCH scores (P = .025 and P < .001, respectively). NLR, number of distal anastomoses, intensive care unit (ICU) stay times, and total hospitalization times were significantly higher in Group 2 (P = .021, P = .021, P < .001, P < .001, respectively). HATCH score was identified as an independent predictor of AF development following OPCABG surgery (OR: 2.125, 95 % CI: 1.296–3.482,
P = .003).
Conclusion: In light of our study, HATCH scores of all patients preoperatively may be calculated so that preventive precautions are taken for high-risk patients.
Aldemir M, Bakı ED, Adalı F, et al. 2015. Comparison of neutrophil: lymphocyte ratios following coronary artery bypass surgery with or without cardiopulmonary bypass. Cardiovasc J Afr 26: 159-64.
Alqahtani AA. 2010. Atrial fibrillation post cardiac surgery trends toward management. Heart Views 11(2): 57–63.
Aviles RJ, Martin DO, Apperson-Hansen C, et al. 2003. Inﬂammation as a risk factor for atrial fibrillation. Circulation 108(24): 3006–3010.
Azab B, Shariff MA, Bachir R, et al. 2013. Elevated preoperative neutrophil/lymphocyte ratio as a predictor of increased long-term survival in minimal invasive coronary artery bypass surgery compared to sternotomy. J Cardiothorac Surg 8: 193.
Bohatch Júnior MS, Matkovski PD, Di Giovanni FJ, et al. 2015. Incidence of postoperative atrial fibrillation in patients undergoing on-pump and off-pump coronary artery bypass grafting. Braz J Cardiovasc Surg 30(3): 316–324.
Bradley D, Creswell L, Hogue CW Jr, et al. 2005. Pharmacologic prophylaxis: American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. Chest. 128(2 Suppl): 39S–47S.
Echahidi N, Pibarot P, O'Hara G, et al. 2008. Mechanisms, prevention, and treatment of atrial fibrillation after cardiac surgery. J Am Coll Cardiol 51: 793–801.
El-Chami MF, Kilgo P, Thourani V, et al. 2010. New-onset atrial fibrillation predicts long-term mortality after coronary artery bypass graft. J Am Coll Cardiol 55:1370–6.
Emren SV, Kocabaş U, Duygu H, et al. 2016. The role of HATCH score in predicting the success rate of sinus rhythm following electrical cardioversion of atrial fibrillation. Kardio Pol. 74(9): 978–984.
Fuster V, Rydén LE, Asinger RW, et al. 2001. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. J Am Coll Cardiol 38:19.
Gibson PH, Croal BL, Cuthbertson BH et al. 2007. Preoperative neutrophil–lymphocyte ratio and outcome from coronary artery bypass grafting. Am Heart J 154(5): 995–1002.
Hallstrom S, Pivodic A, Rosengren A, et al. 2019. Risk Factors for Atrial Fibrillation in People With Type 1 Diabetes: An Observational Cohort Study of 36,258 Patients From the Swedish National Diabetes Registry. Diabetes Care 42(8):1530-1538.
Hashemzadeh K, Dehdilani M, Dehdilani M. 2013. Does Off-pump Coronary Artery Bypass Reduce the Prevalence of Atrial Fibrillation? J Cardiovasc Thorac Res 5(2):45-9.
Heeringa J, van der Kuip DAM, Hofman A, et al. 2007. Subclinical Atherosclerosis and Risk of Atrial Fibrillation: The Rotterdam Study. Arch Intern Med 167(4):382–387.
Laffey JG, Boylan JF, Cheng DC. 2002. The systemic inflammatory response to cardiac surgery: Implications for the anesthesiologist. Anesthesiology 97: 215–252.
Lardizabal JA, Deedwania PC. 2012. Atrial fibrillation in heart failure. Med Clin North Am 96: 987–1000.
Li J, Agarwal SK, Alonso A, et al. 2014. Airflow obstruction, lung function, and incidence of atrial fibrillation: the atherosclerosis risk in communities (ARIC) study. Circulation 129: 971e980.
Lin WS, Liou JT, Yang SP, et al. 2006. Can off-pump coronary artery bypass graft surgery decrease the incidence of postoperative atrial fibrillation? Acta Cardiol Sin 22(4):205-11.
Liu X, Zhang Q, Wu H, et al. 2015. Blood neutrophil to lymphocyte ratio as a predictor of hypertension. Am J Hypertens 28(11):1339-46.
Miao DD, Zang XB, Zhang SL, et al. 2012. Predictive value of HATCH score on atrial fibrillation recurrence post radiofrequency catheter ablation. Zhonghua Xin Xue Guan Bing Za Zhi. 40(10):821-4.
Ozturk S, Kalyoncuoglu M, Sahin M. 2019. Comparison of SYNTAX Score I and SYNTAX Score II for Predicting Postoperative Atrial Fibrillation in Patients Undergoing Coronary Artery Bypass Graft Surgery. Heart Surg Forum 22(5): E319-E324.
Paliogiannis P, Fois AG, Sotgia S, et al. 2018. Neutrophil to lymphocyte ratio and clinical outcomes in COPD: recent evidence and future perspectives. Eur Respir Rev 27: 170113.
Papa A, Emdin M, Passino C, et al. 2008. Predictive value of elevated neutrophil–lymphocyte ratio on cardiac mortality in patients with stable coronary artery disease. Clin Chim Acta 395(1–2): 27–31.
Raja SG, Dreyfus GD. 2008. Current status of off-pump coronary artery bypass surgery. Asian Cardiovasc Thorac 16(2):164-78.
Selvi M, Gungor H, Zencir C, et al. 2017. A new predictor of atrial fibrillation after coronary artery bypass graft surgery: HATCH score. J Investig Med 66(3): 648-652.
Silberman S, Abu-Yunis U, Tauber R, et al. 2018. Neutrophil-lymphocyte ratio: prognostic impact in heart surgery. Early outcomes and late survival. Ann Torac Surg 105: 581-586.
Weymann A, Ali-Hasan-Al-Saegh S, Popov AF, et al. 2018. Hematologic indices as predictors of atrial fibrillation following isolated coronary artery bypass grafting, valvular surgery or combined procedures: A systematic review with meta-analysis. Kardiol Pol. 76(1): 107-118.
Yadava M, Hughay AB, Crawford TC. 2016. Postoperative Atrial Fibrillation Incidence, Mechanisms, and Clinical Correlates. Heart Failure Clin 12:299-308.
How to Cite
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).